More study needed before combination therapies for AMD accepted

Baltimore?Photodynamic therapy (PDT) has been the mainstay of treatment for choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD) until recently when combination therapies (PDT and anti-vascular endothelial growth factor [VEGF]) agents started to be explored.

Related Videos
View All
Related Content
© 2023 MJH Life Sciences

All rights reserved.